Fierce Biotech6d
Pliant, Acelyrin resort to ‘poison pills’ as threat of Concentra buyout looms
With Concentra Biosciences expanding its stock influence in Pliant Therapeutics and Acelyrin, the two biotechs have shored up ...
BioPharma Dive6d
Makary advances to full senate vote; Acelyrin, Pliant adopt ‘poison pills’
President Trump’s nominee to run the FDA secured the Senate HELP Committee’s backing. Elsewhere, Sutro cut jobs and a cell ...
BioSpace6d
Pliant Pops Poison Pill as Concentra Threat Looms
Pliant follows in the footsteps of Acelyrin, which also enacted a stockholder rights program on Thursday to protect ...
Yahoo Finance6d
Makary advances to full senate vote; Acelyrin, Pliant adopt ‘poison pills’
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter.
Yahoo Finance6d
Acelyrin, Inc. (SLRN)
LOS ANGELES, March 13, 2025 (GLOBE NEWSWIRE) -- ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative ...
New York Post6d
Highly venomous male octopuses poison females before sex — to avoid being eaten after mating, scientists say
It’s an octopus-eat-octopus world. Scientists have discovered that when mating, male blue-lined octopuses will inject a powerful, incapacitating neurotoxin into the hearts of female octopuses ...
pharmaphorum4d
ACELYRIN acquires ValenzaBio, strengthens immunology position
ACELYRIN, Inc., a Los Angeles area-based, late-stage clinical biopharma, with additional operations in the San Francisco Bay area, has announced it is acquiring privately held ValenzaBio – which ...